Taiko Pharmaceutical Co Ltd
TSE:4574

Watchlist Manager
Taiko Pharmaceutical Co Ltd Logo
Taiko Pharmaceutical Co Ltd
TSE:4574
Watchlist
Price: 284 JPY -0.35%
Market Cap: ¥14.4B

Operating Margin

3.8%
Current
Improving
by 13.9%
vs 3-y average of -10.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
3.8%
=
Operating Income
¥227m
/
Revenue
¥5.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
3.8%
=
Operating Income
¥227m
/
Revenue
¥5.9B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Taiko Pharmaceutical Co Ltd
TSE:4574
14.3B JPY
Loading...
JP
Hoya Corp
TSE:7741
8.6T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.4B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
36.4B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
119.9B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.1B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY
Loading...
KR
HLB Inc
KOSDAQ:028300
8.7T KRW
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.3B CHF
Loading...

Market Distribution

Lower than 72% of companies in Japan
Percentile
28th
Based on 6 730 companies
28th percentile
3.8%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Taiko Pharmaceutical Co Ltd
Glance View

Market Cap
14.4B JPY
Industry
Health Care

Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs. The company is headquartered in Osaka, Osaka-Fu and currently employs 264 full-time employees. The company went IPO on 2009-03-18. The firm is engaged in three business segments. The Pharmaceutical Product segment is engaged in the manufacturing, sales and export of gastrointestinal drugs under the name SEIROGAN, SEIROGAN TOI-A (sugar coated tablet) and PISHUT. The Infection Control segment is engaged in the planning, development and sales of infection control products, which apply proprietary technique regarding chlorine dioxide gas. The Others segment is engaged in the manufacturing and sales of bath liquid, soap and gardening pyroligneous acid.

Intrinsic Value
236.51 JPY
Overvaluation 17%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
3.8%
=
Operating Income
¥227m
/
Revenue
¥5.9B
What is Taiko Pharmaceutical Co Ltd's current Operating Margin?

The current Operating Margin for Taiko Pharmaceutical Co Ltd is 3.8%, which is above its 3-year median of -10.1%.

How has Operating Margin changed over time?

Over the last 3 years, Taiko Pharmaceutical Co Ltd’s Operating Margin has increased from -96.6% to 3.8%. During this period, it reached a low of -96.6% on Aug 30, 2022 and a high of 10% on Dec 31, 2024.

Back to Top